Epstein Barr Virus Market By Test (Complete Blood Count Test, Monospot test and Others), By Application (Mononucleosis, Gastric Carcinoma, Multiple Sclerosis and Others), and By Region - Market Trends, Analysis, and Forecast till 2030

Numerous academic institutions regularly conduct research and development to create novel monovaccines. For instance, since 2017, the University of Kansas School of Engineering and Pharmacy has been studying the genetics of human immune responses with the goal of creating a potent vaccine against the Epstein-Barr virus (EBV). Growing research efforts by different organizations to develop novel EBV vaccines are expected to propel the global market for Epstein-Barr virus vaccines. Technological developments in serological testing for Epstein-Barr virus infection are driving the market. The market is also being driven by the need for novel treatments for diseases caused by the Epstein-Barr virus. The market is expanding due to both growing public awareness of therapeutic options and technological advancements.